Combination therapy of chronic hepatitis C: An important step but not the final goal!

Journal of Hepatology

Volumn 29, Issue 6, 1998, Pages 1010-1014

  Wedemeyer, H ^a   Caselmann, W H ^a   Manns, M P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; AMANTADINE; RIBAVIRIN; RIMANTADINE; ZIDOVUDINE;

ANEMIA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG RESPONSE; EDITORIAL; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; PRIORITY JOURNAL; REINFECTION; RELAPSE; REPRODUCTIVE TOXICITY;

EID: 0031773286     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80133-5     Document Type: Editorial

References (52)

1. JH Hoofnagle AM di Bisceglie The treatment of chronic viral hepatitis N Engl J Med 336 1997 347 356
2. KL Lindsay Therapy of hepatitis C: overview Hepatology 26 1997 71S 77S
3. RW Sidwell JH Huffman GP Khare LB Allen JT Witkowski RK Robins Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl- 1,2,4-triazole-3-carboxamide Science 177 1972 705 706
4. D Edell E Bruce K Hale V Khoshoo Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants: a preliminary report Pediatr Pulmonol 25 1998 154 158
5. JL Patterson R Fernandez-Larsson Molecular action of ribavirin Rev Infect Dis 12 1990 1332 1346
6. W Heagy C Crumpacker PA Lopez RW Finberg Inhibition of immune functions by antiviral drugs J Clin Invest 87 1991 1916 1924
7. WB Jolley B Sharma R Chami C Ng R Bullington Longterm skin allograft survival by combined therapy with suboptimal dose of cyclosporine and ribavirin Transplant Proc 20 1988 703 706
8. RW Sidwell JH Huffman N Campbell LB Allen Effect of ribavirin on viral hepatitis in laboratory animals Ann N Y Acad Sci 284 1977 239 246
9. MW Vogt KL Hartshorn PA Furman TC Chou JA Fyfe LA Coleman Ribavirin antagonizes the effect of azido-thymidine on HIV replication Science 235 1987 1376 1379
10. Q Ning D Brown J Parodo M Cattral R Gorczynski E Cole Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response J Immunol 160 1998 3487 3493
11. FV Chisari C Ferrari Hepatitis B virus immunopathogenesis Annu Rev Immunol 13 1995 29 60
12. RL Modlin TB Nutman Type 2 cytokines and negative immune regulation in human infections Curr Opin Immunol 5 1993 511 517
13. P Botarelli MR Brunetto MA Minutello P Calvo D Unutmaz AJ Weiner T-lymphocyte response to hepatitis C virus in different clinical courses of infection Gastroenterology 104 1993 580 587
14. RP Woitas M Lechmann G Jung R Kaiser T Sauerbruch U Spengler CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes J Immunol 159 1997 1012 1018
15. JE Allen RM Maizels Th1-Th2: reliable paradigm or dangerous dogma? Immunol Today 18 1997 387 392
16. M Lechmann HG Ihlenfeldt I Braunschweiger G Giers G Jung B Matz T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia Hepatology 24 1996 790 795
17. HC Bodenheimer Jr. KL Lindsay GL Davis JH Lewis SN Thung LB Seeff Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial Hepatology 26 1997 473 477
18. G Dusheiko J Main H Thomas O Reichard C Lee A Dhillon Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study J Hepatol 25 1996 591 598
19. AM di Bisceglie HS Conjeevaram MW Fried R Sallie Y Park C Yurdaydin Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial Ann Intern Med 123 1995 897 903
20. J Koskinas C Tibbs MG Saleh LM Pereira IG McFarlane R Williams Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients J Med Virol 45 1995 29 34
21. J Camps N Garcia JI Riezu-Boj MP Civeira J Prieto Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon J Hepatol 19 1993 408 412
22. AM di Bisceglie M Shindo TL Fong MW Fried MG Swain NV Bergasa A pilot study of ribavirin therapy for chronic hepatitis C Hepatology 16 1992 649 654
23. O Reichard J Andersson R Schvarcz O Weiland Ribavirin treatment for chronic hepatitis C Lancet 337 1991 1058 1061
24. JH Hoofnagle D Lau H Conjeevaram D Kleiner AM di Bisceglie Prolonged therapy of chronic hepatitis C with ribavirin J Viral Hepat 3 1996 247 252
25. CE Long KZ Voter WH Barker CB Hall Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo Pediatr Infect Dis J 16 1997 1023 1028
26. AM di Bisceglie BR Bacon DE Kleiner JH Hoofnagle Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C J Hepatol 21 1994 1109 1112
27. BS Levine MT Tomlinson RP Parker Onset and reversibility of ribavirin-induced testicular toxicity in mice Toxic Substances Journal 13 1994 171 186
28. L Chemello L Cavalletto E Bernardinello M Guido P Pontisso A Alberti The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C J Hepatol 23 1995 8 12 Suppl 2
29. JH Braconier O Paulsen K Engman A Widell Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot study Scand J Infect Dis 27 1995 325 329
30. MY Lai JH Kao PM Yang JT Wang PJ Chen KW Chan Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C Gastroenterology 111 1996 1307 1312
31. O Reichard G Norkrans A Fryden JH Braconier A Sonnerborg O Weiland Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group Lancet 351 1998 83 87
32. T Poynard P Marcellin S Lee C Niederau G Minuk G Ideo An international randomized trial of interferon alfa-2B and ribavirin (Intron A/Rebetol) 48 or 24 weeks vs. interferon alfa-2B Intron A 48 weeks, for first line treatment of chronic hepatitis C [abstract] Hepatology 28 1998 387A Suppl. 2
33. J McHutchison S Gordon E Schiff E Shiffman W Lee V Rustgi Interferon alfa 2b alone or in combination with ribavirin in naive chronic HCV patients: a US multicentre trial [abstract] Hepatology 28 1998 387A (Suppl. 2)
34. S Brillanti J Garson M Foli K Whitby R Deaville C Masci A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C Gastroenterology 107 1994 812 817
35. L Chemello L Cavalleto E Bernardinello C Donada F Belussi P Casarin Retreatment of chronic hepatitis C (CHC) with sequential interferon-ribavirin combination therapy [abstract] J Hepatol 28 1998 109
36. R Schvarcz ZB Yun A Sonnerborg O Weiland Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone J Med Virol 46 1995 43 47
37. GL Davis R Esteban V Rustgi JC Hoefs SC Gordon C Trepo Retreatment of relapse after interferon therapy for chronic hepatitis C: an international randomized controlled trial of interferon plus ribavirin vs interferon alone [abstract] Hepatology 26 1997 247A
38. SW Schalm BE Hansen L Chemello A Bellobuono JT Brouwer O Weiland Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers J Hepatol 26 1997 961 966
39. A Bellobuono L Mondazzi S Tempini E Silini F Vicari G Ideo Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial J Viral Hepat 4 1997 185 191
40. G Scotto V Fazio G Tantimonaco Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone Ital J Gastroenterol 28 1996 505 511
41. H Wedemeyer E Jaeckel J Wedemeyer H Franck A Schueler C Trautwein Re-treatment of chronic hepatitis C with interferon alpha and ribavirin in non-responders to interferon alpha monotherapy - analysis of the own experience and review of the literature Z Gastroenterol 36 1998 819 827
42. S Brillanti M Foli M Di Tomaso L Gramantier C Masci L Bolondi Response to triple antiviral therapy in interferon non-responders with chronic hepatitis C [abstract] J Hepatol 28 1998 114
43. KH Boker G Dalley MJ Bahr H Maschek HL Tillmann C Trautwein Long-term outcome of hepatitis C virus infection after liver transplantation Hepatology 25 1997 203 210
44. HR Rosen PM O'Reilly CR Shackleton S McDiarmid C Holt RW Busuttil Graft loss following liver transplantation in patients with chronic hepatitis C Transplantation 62 1996 1773 1776
45. EJ Gane BC Portmann NV Naoumov HM Smith JA Underhill PT Donaldson Long-term outcome of hepatitis C infection after liver transplantation [see comments] N Engl J Med 334 1996 815 820
46. MC Shuhart MP Bronner DR Gretch LV Thomassen CF Wartelle H Tateyama Histological and clinical outcome after liver transplantation for hepatitis C Hepatology 26 1997 1646 1652
47. T Bizollon U Palazzo C Ducerf M Chevallier M Elliott J Baulieux Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation Hepatology 26 1997 500 504
48. C Feray D Samuel M Gigou V Paradis MF David C Lemonnier An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection Hepatology 22 1995 1084 1099
49. TL Wright C Combs M Kim L Ferrell P Bacchetti N Ascher Interferon-alpha therapy for hepatitis C virus infection after liver transplantation Hepatology 20 1994 773 779
50. WH Caselmann S Eisenhardt M Alt Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C Intervirology 40 1997 394 399
51. M Alt R Renz PH Hofschneider WH Caselmann Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation Arch Virol 142 1997 589 599
52. M Alt R Renz PH Hofschneider G Paumgartner WH Caselmann Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides Hepatology 22 1995 707 717